Elsevier

Biochemical Pharmacology

Volume 43, Issue 8, 15 April 1992, Pages 1872-1875
Biochemical Pharmacology

Short communication
Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation

https://doi.org/10.1016/0006-2952(92)90725-XGet rights and content

Abstract

Increases in lipid peroxide in kidneys of rats treated with cisplatin were examined in relation to decreases in the activities of Cu,Zn-superoxide dismutase (Cu,Zn-SOD), Mn-SOD, glutathione peroxidase (GSHpx), glutathione S-transferase (GST) and catalase. The activities of catalase, GSHpx and GST in the kidney and the liver were significantly decreased after cisplatin administration. The decrease of GST activity in the kidney was 87.3%, this was the largest decrease among these enzymes in the tissues examined. Cu,Zn-SOD activity significantly decreased only in the kidney. In contrast, the activities of these enzymes in the heart and the lung, which showed no increase in lipid peroxide in our previous study, were not significantly decreased. Cisplatin does not directly increase lipid peroxidation in vitro; therefore, the increase of lipid peroxide in the kidneys of these rats treated with cisplatin can be attributed to a decrease in the activities of lipid peroxide-protecting enzymes.

References (12)

There are more references available in the full text version of this article.

Cited by (129)

  • Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs

    2022, Life Sciences
    Citation Excerpt :

    Increased PKG activity also prevents the mitochondrial membrane potential loss induced by cisplatin in the tubular cells (Table 1) [83]. Toxic, highly reactive oxygen free radicals are induced by cisplatin, which causes a rise in lipid peroxidation and a decrease in the enzyme activity that protects the body from lipid peroxidation as well as a reduction in the body's antioxidant status and results in nephrotoxicity [84–86]. Furthermore, reactive nitrogen species have been linked to the mechanism of nephrotoxicity induced by cisplatin, which is characterized by a rise in renal peroxynitrite and nitric oxide levels [87,88].

  • Protective effects of sesamol against cisplatin-induced nephrotoxicity in rats: A mechanistic approach

    2020, Obesity Medicine
    Citation Excerpt :

    Nephrotoxicity is one of the major toxic side effect in 20% of cisplatin-treated cancer patients, which limiting its use in chemotherapy (Dos et al., 2012). Oxidative stress induced by CP treatment in cancer patients, activates various inflammatory mediators that promote lipid oxidation and causes DNA damage in proximal and distal tubules in the kidney (Sadzuka et al., 1992). Antioxidants showed various pharmacological activities and spread widely in nature.

  • Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease

    2019, Redox Biology
    Citation Excerpt :

    It is known that the major site of cisplatin-induced nephrotoxicity is in proximal tubule cells [3], where cisplatin forms glutathione (GSH) and cysteine conjugates, which undergo metabolic activation to form reactive thiols [18]. Cisplatin accumulates in the mitochondria of tubular epithelial cells, causes mitochondrial structural damage, increases in steady-state levels of reactive oxygen species (ROS), and decreases in total GSH and superoxide dismutase (SOD) activity [16,19–21]. Impaired mitochondrial metabolism reduces mitochondrial electron transport chain (ETC) efficiency, increases ROS—more specifically superoxide (O2•-)—and reduces ATP generation [13,15,21,22].

View all citing articles on Scopus
View full text